Kimberly Gentile, SVP, Clinical Operations at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 24,000 shares at $70.20 ($1.7M) on 2020-06-17, disclosed to the SEC on 2020-06-17.
Open-market sale of $1.7M BHVN by SVP, Clinical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BHVN | SELL | 2020-06-10 | $42K | — | Filing → |
| BHVN | SELL | 2019-11-22 | $2.7M | — | Filing → |
| BHVN | SELL | 2018-06-19 | $1.0M | — | Filing → |